Evidence map›Paper›PMID 34276305›Full record

ArticleFrontiers in molecular neuroscience2021

Bisulfite Amplicon Sequencing Can Detect Glia and Neuron Cell-Free DNA in Blood Plasma.

Zac Chatterton, Natalia Mendelev, Sean Chen, Walter Carr, Gary H Kamimori, Yongchao Ge, Andrew J Dwork, Fatemeh Haghighi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Detection of Brain-Derived Cell-Free DNA in Plasma.Diagnostics (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Cell-free DNA-based liquid biopsies in neurology.Brain : a journal of neurology · 2023
    Review
  8. Article
  9. Brain-derived cell-free DNA.Neural regeneration research · 2022
    Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Zac ChattertonFriedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Natalia MendelevFriedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Sean ChenFriedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Walter CarrWalter Reed Army Institute of Research, Silver Spring, MD, United States.
Gary H KamimoriWalter Reed Army Institute of Research, Silver Spring, MD, United States.
Yongchao GeDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Andrew J DworkDepartment of Pathology and Cell Biology, Columbia University, New York, NY, United States.
Fatemeh HaghighiFriedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Icahn School of Medicine at Mount Sinai · USJames J. Peters VA Medical Center · USAllen Institute for Brain Science · USNew York Psychoanalytic Society and Institute · USOak Ridge Associated Universities · USWalter Reed Army Institute of Research · US

Funding

Golgi Studies of SchizophreniaR01MH064168 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI DWORK, ANDREW J · 2001 to 2013
$4.3M
Building Schizophrenia Research in MacedoniaR01MH098786 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DWORK, ANDREW J, ROSOKLIJA, GORAZD B. · 2012 to 2016
$2.2M
BLRD VA I01 BX003794CSRD VA I01 CX001395CSRD VA I01 CX001728CSRD VA IK6 CX002074NIMH NIH HHS R01 MH064168NIMH NIH HHS R01 MH098786RRD VA I01 RX001705
6 · The paper itself

Abstract

Sampling the live brain is difficult and dangerous, and withdrawing cerebrospinal fluid is uncomfortable and frightening to the subject, so new sources of real-time analysis are constantly sought. Cell-free DNA (cfDNA) derived from glia and neurons offers the potential for wide-ranging neurological disease diagnosis and monitoring. However, new laboratory and bioinformatic strategies are needed. DNA methylation patterns on individual cfDNA fragments can be used to ascribe their cell-of-origin. Here we describe bisulfite sequencing assays and bioinformatic processing methods to identify cfDNA derived from glia and neurons. In proof-of-concept experiments, we describe the presence of both glia- and neuron-cfDNA in the blood plasma of human subjects following mild trauma. This detection of glia- and neuron-cfDNA represents a significant step forward in the translation of liquid biopsies for neurological diseases.

Indexed as

cfDNAdiagnosticepigeneticglianeuronneurotrauma

Identifiers

PMID34276305
PMCPMC8283182
OpenAlexW3185003204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.